Bleomycin and durvalumab inside people together with germline BRCA-mutated stage 4 cervical cancer (MEDIOLA): a good open-label, multicentre, cycle 1/2, holder examine | #lenvatinib #bleomycin #pik-5
Bleomycin and durvalumab inside people together with germline BRCA-mutated stage 4 cervical cancer (MEDIOLA): a good open-label, multicentre, cycle 1/2, holder examine | #lenvatinib #bleomycin #pik-5